| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |